228 related articles for article (PubMed ID: 22530772)
1. IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology.
Arshad MI; Piquet-Pellorce C; Samson M
Liver Int; 2012 Sep; 32(8):1200-10. PubMed ID: 22530772
[TBL] [Abstract][Full Text] [Related]
2. The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.
Yu SL; Wong CK; Tam LS
Expert Rev Clin Immunol; 2013 Aug; 9(8):739-49. PubMed ID: 23971752
[TBL] [Abstract][Full Text] [Related]
3. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
[TBL] [Abstract][Full Text] [Related]
4. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
Andersson U; Yang H; Harris H
Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.
Wang X; Sun R; Wei H; Tian Z
Hepatology; 2013 Jan; 57(1):373-84. PubMed ID: 22821628
[TBL] [Abstract][Full Text] [Related]
7. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
[TBL] [Abstract][Full Text] [Related]
8. TLR4, IL-6, IL-18, MyD88 and HMGB1 are highly expressed in intracranial inflammatory lesions and the IgG4/IgG ratio correlates with TLR4 and IL-6.
Hirano H; Yoshioka T; Yunoue S; Fujio S; Yonezawa H; Niiro T; Habu M; Oyoshi T; Sugata S; Kamezawa T; Arimura H; Hanaya R; Tokimura H; Tokudome M; Arita K
Neuropathology; 2012 Dec; 32(6):628-37. PubMed ID: 22414145
[TBL] [Abstract][Full Text] [Related]
9. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
10. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
11. Involvement of HMGB1 and RAGE in IL-1β-induced gingival inflammation.
Ito Y; Bhawal UK; Sasahira T; Toyama T; Sato T; Matsuda D; Nishikiori H; Kobayashi M; Sugiyama M; Hamada N; Arakawa H; Kuniyasu H
Arch Oral Biol; 2012 Jan; 57(1):73-80. PubMed ID: 21861984
[TBL] [Abstract][Full Text] [Related]
12. Is HMGB1 an osteocyte alarmin?
Bidwell JP; Yang J; Robling AG
J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
[TBL] [Abstract][Full Text] [Related]
13. The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.
Yang Q; Liu Y; Shi Y; Zheng M; He J; Chen Z
Immunobiology; 2013 Oct; 218(10):1284-92. PubMed ID: 23706499
[TBL] [Abstract][Full Text] [Related]
14. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins.
Bertheloot D; Latz E
Cell Mol Immunol; 2017 Jan; 14(1):43-64. PubMed ID: 27569562
[TBL] [Abstract][Full Text] [Related]
15. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
[TBL] [Abstract][Full Text] [Related]
16. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic levels of cytokines and danger signals in endometriosis-affected women.
Jaeger-Lansky A; Schmidthaler K; Kuessel L; Gstöttner M; Waidhofer-Söllner P; Zlabinger GJ; Wenzl R; Eiwegger T
J Reprod Immunol; 2018 Nov; 130():7-10. PubMed ID: 30099220
[TBL] [Abstract][Full Text] [Related]
19. Alarmins and Related Molecules in Elective Surgery.
Strohalmová S; Levová K; Kuběna AA; Hoskovec D; Krška Z; Zima T; Kalousová M
Folia Biol (Praha); 2023; 69(2):50-58. PubMed ID: 38063001
[TBL] [Abstract][Full Text] [Related]
20. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
